COVID-19 VACCINATION AVAILABLE

No Health Insurance Needed.

PRE-REGISTER HERE

1.Which vaccine is being given and what are its details?

Name: JNJ-78436735
Manufacturer: Janssen Pharmaceuticals Companies of Johnson & Johnson.Type of vaccine: Viral vector

Number of shots: 1 shot

How given: Shot in the muscle of the upper arm

Does not contain:

  • Eggs
  • Preservatives
  • Latex

2. Who should get vaccinated

The J&J/Janssen vaccine is recommended for people aged 18 years and older.

3. Who should not get vaccinated

If you have had a severe allergic reaction (anaphylaxis) or an immediate allergic reaction—even if it was not severe—to any ingredient (https://www.fda.gov/media/146305/download) in the J&J/Janssen COVID-19 vaccine (such as polysorbate), you should not get the J&J/Janssen COVID-19 vaccine. An allergic reaction is considered severe when a person needs to be treated with epinephrine or EpiPen© or if they must go to the hospital. Experts refer to severe allergic reactions as anaphylaxis. Learn about common side effects of COVID-19 vaccines (https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html) and when to call a doctor. An immediate allergic reaction means a reaction within 4 hours of getting vaccinated, including symptoms such as hives, swelling, or wheezing (respiratory distress).

4. What are the possible side effects?

Most common side effects

In the arm where you got the shot:

  • Pain
  • Redness
  • Swelling

Throughout the rest of your body:

  • Tiredness
  • Headache
  • Muscle pain
  • Chills
  • Fever
  • Nausea

These side effects usually start within a day or two of getting the vaccine. Side effects might affect your ability to do daily activities, but they should go away in a few days.

Summary of safety data

  • In clinical trials, side effects were common within 7 days of getting vaccinated but were mostly mild to moderate.
  • Side effects were more common in people 18–59 years old compared to people 60 years and older.
  • CDC will continue to provide updates as we learn more about the safety of the J&J/Janssen vaccine in real-world conditions.

5. How does this vaccine work?

  • The J&J/Janssen vaccine was 66.3% effective in clinical trials(efficacy) at preventing laboratory-confirmed COVID-19 illness in people who had no evidence of prior infection 2 weeks after receiving the vaccine. People had the most protection 2 weeks after getting vaccinated.
  • The vaccine had high efficacy at preventing hospitalization and death in people who did get sick. No one who got COVID-19 at least 4 weeks after receiving the J&J/Janssen vaccine had to be hospitalized.
  • Early evidence suggests that the J&J/Janssen vaccine might provide protection against asymptomatic infection, which is when a person is infected by the virus that causes COVID-19 but does not get sick.
  • CDC will continue to provide updates as we learn more about how well the J&J/Janssen vaccine works in real-world conditions.

SUPPORT OUR EFFORTS

Help us bring healthcare services to underserved populations throughout Greater Houston.
Scroll to Top